Search Results - "Menkès, C J"

Refine Results
  1. 1
  2. 2

    Quantitative assessment of joint space width with an electronic caliper by Hilliquin, P., Pessis, E., Coste§, J., Mauget, D., Azria, A., Chevrot, A., Menkès, C.-J., Kahan, A.

    Published in Osteoarthritis and cartilage (01-07-2002)
    “…The progression of joint space narrowing (JSN) is considered to be the best available marker of osteoarthritis (OA) progression. Several techniques have been…”
    Get full text
    Journal Article
  3. 3

    The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience by Kahan, A, Menkès, C J

    Published in Lupus (01-06-1996)
    “…A significant proportion of patients with rheumatoid arthritis have an aggressive, severe disease that may contribute to excess mortality. It has been…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis by REGINSTER, J. Y, KUNTZ, D, VERDICKT, W, WOUTERS, M, GUILLEVIN, L, MENKES, C.-J, NIELSEN, K

    Published in Osteoporosis international (1999)
    “…One hundred and forty-five patients suffering from diseases requiring long-term treatment with high doses of corticosteroids (30 mg/day or greater of…”
    Get full text
    Journal Article Web Resource
  6. 6

    Reduced incidence and prevalence of atopy in rheumatoid arthritis. Results of a case–control study by Hilliquin, P., Allanore, Y., Coste, J., Renoux, M., Kahan, A., Menkès, C. J.

    Published in Rheumatology (Oxford, England) (01-09-2000)
    “…Objective. To determine the cumulative incidence and the point prevalence of atopy in patients with rheumatoid arthritis (RA). Patients and methods. A…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap by Duruöz, M T, Poiraudeau, S, Fermanian, J, Menkes, C J, Amor, B, Dougados, M, Revel, M

    Published in Journal of rheumatology (01-07-1996)
    “…To construct a functional disability scale for the rheumatoid hand and to determine if this scale also assesses functional handicap. Outpatients and inpatients…”
    Get more information
    Journal Article
  9. 9

    Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis by Hilliquin, P, Dulioust, A, Gregoir, C, Arnoux, A, Menkés, C J

    Published in Inflammation research (01-08-1995)
    “…PAF-acether (PAF) is a pro-inflammatory phospholipid molecule potentially involved in the pathogenesis of arthritis. PAF and related metabolites have been…”
    Get full text
    Journal Article
  10. 10

    Decreased prevalence of atopy in rheumatoid arthritis by Allanore, Y, Hilliquin, P, Coste, J, Renoux, M, Menkés, CJ

    Published in The Lancet (British edition) (14-02-1998)
    “…Allanore et al investigated the cumulative incidence and point prevalence of allergic asthma, hay fever, and atopic eczema in patients with rheumatoid…”
    Get full text
    Journal Article
  11. 11

    Pharmacodynamic effect of nicardipine on left ventricular function in systemic sclerosis by Kahan, A, Devaux, J Y, Amor, B, Menkès, C J, Weber, S, Guérin, F, Venot, A, Strauch, G

    Published in Journal of cardiovascular pharmacology (01-02-1990)
    “…Left ventricular dysfunction in systemic sclerosis may be due in part to myocardial ischemia caused by a disturbance in coronary microcirculation. We evaluated…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Guidelines for testing slow acting drugs in osteoarthritis by Lequesne, M, Brandt, K, Bellamy, N, Moskowitz, R, Menkes, C J, Pelletier, J P, Altman, R

    Published in Journal of rheumatology. Supplement (01-09-1994)
    “…New compounds appear to improve symptoms of osteoarthritis (OA), and others are putative chondroprotective agents. We suggest experimental designs for studying…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis by Kahan, A, Devaux, J Y, Amor, B, Menkès, C J, Weber, S, Nitenberg, A, Venot, A, Guérin, F, Degeorges, M, Roucayrol, J C

    Published in The New England journal of medicine (29-05-1986)
    “…Heart disease in patients with progressive systemic sclerosis may be due in part to myocardial ischemia caused by a disturbance of the coronary…”
    Get more information
    Journal Article
  16. 16

    A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis by MOLHO, P., VERRIER, P., STIELTJES, N., SCHACHER, J.-M., OUNNOUGHÈNE, N., VASSILIEFF, D., MENKES, C.-J., SULTAN, Y.

    “…Between 1970 and 1994, 116 chemical and 90 radioactive synovectomies were performed in 107 patients with severe haemophilia and two with type 3 von…”
    Get full text
    Journal Article
  17. 17

    Better results with rhenium-186 radiosynoviorthesis than with cortivazol in rheumatoid arthritis (RA): A two-year follow-up randomized controlled multicentre study by TEBIB, J. G, MANIL, L. M, MÖDDER, G, VERRIER, P, DE RYCKE, Y, BONMARTIN, A, DEVAUX, J.-Y, CHOSSAT, F, MENKES, C. J, KAHAN, A

    Published in Clinical and experimental rheumatology (01-09-2004)
    “…The aim of this international multicentric randomized phase 3 clinical trial was to compare prospectively radiosynoviorthesis (RSO) with rhenium-186-sulfide…”
    Get full text
    Journal Article
  18. 18

    Physical and biological dosimetry in patients undergoing radiosynoviorthesis with erbium-169 and rhenium-186 by MANIL, L, VOISIN, P, AUBERT, B, GUERREAU, D, VERRIER, P, LEBÈGUE, L, WARGNIES, J.-P, DI PAOLA, M, BARBIER, Y, CHOSSAT, F, MENKES, C J, TÉBIB, J, DEVAUX, J.-Y, KAHAN, A

    Published in Nuclear medicine communications (01-04-2001)
    “…Physical and biological dosimetry were investigated in 45 rheumatoid arthritis patients treated by radiosynoviorthesis (RSO) with Re-sulphide (medium-sized…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Inhibition of the nitrosothiol production of cultured osteoarthritic chondrocytes by rhein, cortisol and diclofenac by Borderie, D., Hernvann, A., Lemarechal, H., Menkes, C.-J., Ekindjian, O.

    Published in Osteoarthritis and cartilage (01-01-2001)
    “…Objective Nitric oxide (NO°) is a free molecule produced by NO synthases which acts as a mediator in inflammatory processes. NO° can react with thiol groups of…”
    Get full text
    Journal Article
  20. 20

    Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis by Menkes, C J, Renoux, M, Laoussadi, S, Mauborgne, A, Bruxelle, J, Cesselin, F

    Published in Journal of rheumatology (01-04-1993)
    “…Experimental results suggest that substance P (SP) may play an important role in pain and inflammation in rheumatic diseases. Measurements of SP-like…”
    Get more information
    Journal Article